Position in AZN
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$1,397,309
-$11,236 QoQ
Shares Held
7,369
+3.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#588
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MITCHELL & PAHL PRIVATE WEALTH, LLC holds $18,659,233 across 8 Drug Manufacturers - General names. AZN ranks #5 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
18,704 | $4,750,254 | |
| 2 | ABBV |
AbbVie Inc.
|
15,598 | $3,925,080 | |
| 3 | NVS |
Novartis AG
|
23,278 | $3,648,128 | |
| 4 | AMGN |
Amgen Inc
|
7,175 | $2,598,211 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
7,369 | $1,397,309 | |
| 6 | MRK |
Merck & Co., Inc.
|
9,886 | $1,270,351 | |
| 7 | NVO |
Novo Nordisk A S
|
17,814 | $854,003 | |
| 8 | LLY |
ELI LILLY & Co
|
180 | $215,897 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,397,309 | 7,369 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $1,408,545 | 7,142 | Shares | Sole | 2026-04-24 | |
| No filing history on record for this holder in this stock. | ||||||